Research News

Professor Ricard González-Cinca, head of the Space Exploration Laboratory, linked to the group BIOCOM-SC at the Physics department, is participating in this pioneering experiment for the management of cryogenic fuels in space

Candidate Yu Yin defended his thesis co-directed by Guillermo González and Angela Aragon-Angel on March 3 at Campus Nord. Titled "Innovative Contributions to Ionospheric Scintillation Monitoring using GNSS Observations," this thesis presents solid research that significantly advances scintillation monitoring with accurate, economical, and wide-coverage solutions, improving GNSS performance in complex ionospheric conditions

Ming Zeng defended his thesis co-directed by Pol Lloveras and Josep Lluís Tamarit, on December 4, 2024 at the Besòs Campus. Entitled "Barocaloric and multicaloric effects under hydrostatic pressure and electric field", the thesis presents the caloric effects in first-order phase transitions in solids of different types. These effects are of interest for efficient and sustainable refrigeration applications.

Andreu Puy defended his thesis supervised by Romualdo Pastor-Satorras on January 21, 2024 at Campus Nord. Entitled “Dynamic social patterns and information transfer in schooling fish”, the thesis focuses on empirically investigating and using theoretical models the collective movement in schools of fish, analyzing social interactions, information transmission, risk perception effects, and criticality signatures

Zheyao Hu, a student with a scholarship from the China Scholarship Council, defended her doctoral thesis entitled “In silico design of inhibitors of RAS oncogenic proteins and strategies for blocking of tumour growth” and directed by Dr. Jordi Martí Rabassa on January 14, 2025 at the UPC North Campus. The thesis presents a detailed study of the behavior of oncogenes of the RAS family, related to a third of all cancers that exist, and proposes a new methodology to achieve the computer design of drugs capable of blocking the activation of oncogenes. As an example, two prototype drugs are proposed, one of them potentially suitable for treating patients with pancreatic cancer and another for patients with melanoma